Sustained DMARD-free remission in subgroups of patients with rheumatoid arthritis: an analysis of two prospective cohorts with early arthritis
- 20 December 2024
- journal article
- Published by Elsevier in The Lancet Rheumatology
- Vol. 7 (4) , e252-e260
Abstract
No abstract availableKeywords
Funding Information
- Horizon 2020 (714312)
- Pfizer (WI229707)
- Dutch Arthritis Association
- European Research Council
- Horizon 2020
This publication has 28 references indexed in Scilit:
- Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trialThe Lancet Rheumatology, 2024
- Sustained DMARD-free remission in rheumatoid arthritis – about concepts and moving towards practiceJoint Bone Spine, 2022
- Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR databaseRheumatology, 2021
- Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in RemissionJAMA, 2021
- Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practiceClinical Rheumatology, 2018
- Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remissionClinical Rheumatology, 2016
- Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trialThe Lancet, 2016
- Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trialThe Lancet, 2013
- Prevalence of and predictive factors for sustained disease‐modifying antirheumatic drug–free remission in rheumatoid arthritis: Results from two large early arthritis cohortsArthritis & Rheumatism, 2009
- How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritisArthritis & Rheumatism, 2002